过氧化物促进结肠上皮细胞的自,以保护性结肠炎中肠道屏障功能
Wenxin Xia1, Haochang Lin1, Jing Zhang1
1Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, 639 Long Mian Avenue, Nanjing 211198, China. yuedaicpu@cpu.edu.cn.
Food & function
|June 17, 2025
概括
超氧化物 (Hyp) 通过增强自和结蛋白表达来保护性结肠炎的肠壁. 这种天然化合物为炎症性肠病提供了有前途的治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肠道屏障缺陷是性结肠炎 (UC) 发展的关键.
- 超氧化物 (Hyp) 是一种天然的黄醇糖化物,具有潜在的抗结肠炎作用.
研究的目的:
- 为了研究Hyp对UC肠道屏障的保护作用.
- 探索 Hyp 作用背后的机制,重点关注与屏障相关的蛋白质和自.
主要方法:
- 在小鼠中的DSS诱导性结肠炎模型.
- 使用人类结肠上皮细胞进行体外研究.
- 对紧密结合和粘附结合蛋白的分析.
- 与自相关的蛋白质表达和通路分析.
- 自抑制剂 (chloroquine) 和蛋白酶体抑制剂 (MG132) 的作用.
主要成果:
- 在DSS诱导的大肠炎中保持肠道屏障完整.
- 它增加了紧接口 (occludin,claudin 1) 和粘附接口 (E-cadherin,β-catenin) 蛋白质.
- 在人类结肠细胞中减少了LPS诱导的屏障缺陷.
- 催眠促进了牛通过自的降解,而不是蛋白质体的降解.
- 低救助的LPS损害了自,增加了自细胞/溶酶体的形成和关键的自蛋白.
- 氨酸在体外和体外模型中逆转了Hyp对屏障功能的保护作用.
结论:
- 超氧化物在性结肠炎中保护结肠粘膜屏障.
- 希普的机制包括增强自和恢复结蛋白表达.
- Hyp为UC治疗提出了一种新的治疗策略.
相关概念视频
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Delivery Pathways to the Lysosome
7.4K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.4K
Drugs for Treatment of Ulcerative Colitis in IBD
244
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
244
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.2K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
609
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
609
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
709
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
709


